Fermenta Biotech Limited SHARE PRICE [LIVE]
Open: | |
High: | |
Low: |
MKT Cap: | |
52-wk High: | |
52-wk Low: |
Prev close: | |
P/E: | |
Div yield: |
Fundamental analysis
What is not working for the company?
What is working for the company?
Name | Dec 22 | Sep 22 |
---|---|---|
Promoters (Change:-0.00) | 59.58% | 59.58% |
FIIs (Change:-0.01) | 0% | 0.01% |
Mutual Funds (Change:-0.00) | 0% | 0% |
Insurance Companies (Change:0.00) | 0% | 0% |
Other DIIs (Change:-0.04) | 0.01% | 0.05% |
Non Institution (Change:0.06) | 40.41% | 40.35% |
Similar Stocks
Return Calculator
This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.
If I had made LUMPSUM investment of ₹ 1,00,000
in Fermenta Biotech Limited
Months ago
My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %
News
Frequently Asked Questions
What is the Share price of Fermenta Biotech Limited ()?
Can I buy Fermenta Biotech Limited () shares?
How do I buy Fermenta Biotech Limited () from Angel One?
- Direct investment: You can buy Fermenta Biotech Limited () shares by opening a Demat account with Angel One.
- Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Fermenta Biotech Limited () shares.
About
Today's live share price for Fermenta Biotech Limited is NSE: N/A, BSE: ₹ 112.05 with a current market capitalization of .
Promoted by a technocrat, D V K Raju, Duphar-Interfran (DIL) was incorporated in May '51 as International Franchises Pvt Ltd. In the initial years, the company manufactured and sold toothpaste, anti-septic lotion and pharmaceutical specialities on a loan-licence basis. It entered into collaborations with Philips-Duphar, Amsterdam (Solvay Duphar), and the Crookes Laboratories, London. These collaborators participated in the equity capital of the company to the extent of 25% each. The company changed its name to Crookes Interfran on 19 Apr.'63. In 1964, it entered into a collaboration with Solvay Duphar to manufacture vitamin D3. To associate fully with its research-oriented collaborators, in May '71, it changed its name to Duphar-Interfran. In 1976, it entered into another collaboration with Solvay Duphar to manufacture isoxypurine hydrochloride -- a vasodilator. In 1976, in compliance with the FERA, the foreign collaborators reduced thier stake to 38.86%. DIL came out with a rights issue in May '95 to augment long-term resources and working capital requirements. The company also sold its popular analgesic brand Crocin to Smithkline Beecham Pharmaceuticals. It also sold another OTC brand, Lacto-Calamine lotion to Nicholas Piramal to concentrate on the core business of ethical drugs. As per the Scheme of Arrangement, the pharma business of the company has been transferred to a new company called Duphar Pharma India. The Company has made investments in unutilised premises at Thane to create a commercial complex with modern facilities so that substantial portion of it can be let out to earn income. The successful entry of Annual Contract with Solvay Pharmaceuticals B V of Netherlands will definitely establish as a reliable contract research organization for Duphar Interfran Ltd. As mutual consent with Solvay Pharmaceuticals,Netherlands,the company has been permitted to continue with the name DUPHAR for a limited time. It has also been decided to change the name to DIL Limited from Duphar-Interfran Ltd. With the prior approval from Board the company has acquired 990,000 equity shares of Rs.10 each in Fermenta Biotech Ltd there by increase its holding to 83.71% comprising 16,57,500 equity shares. Subsequent to this FBL will henceforth be a subsidiary of Duphar Interfran Ltd.
Read more